Form D · Biotechnology
CEL SCI CORP
Vienna, VA · CIK 0000725363
Offering snapshot reported Jul 11, 2018 · SEC filing
- Reported sold
- $78K Offering amount: $78K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 2, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2018 | Initial | $78,000 | No comparison | 4 | SEC filing |
| Jul 17, 2017 | Initial | $0 | No comparison | 6 | SEC filing |
| Feb 28, 2017 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5.46K
- Finders' fees
- $0
- Form D file number
- 021-316458
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright | 375 |
Source: Form D, filed Jul 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruno Bailavoine | Director |
| Bruno Baillavoine | Director |
| John Cipriano | Executive |
| Alexander Esterhazy | Director |
| Geert Kersten | Director, Executive |
| Patricia B. Prichep | Executive |
| Eyal Talor | Executive |
| Robert Watson | Director |
| Peter R. Young | Director |
| Daniel H. Zimmerman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8229 Boone Blvd . Suite 802
Vienna, VA, 22182
Vienna, VA, 22182